Navigation Links
The 5-Minute Orthopaedic Consult

ProductsThe 5-Minute Orthopaedic Consult
Company Skyscape, Inc.
Item The 5-Minute Orthopaedic Consult
Features 
  • Nearly 200 specific orthopaedic conditions covered
  • Diagnosis Section for each condition covers signs and symptoms, differential diagnosis, physical examination, pathologic findings, and imaging procedures
  • Provides comprehensive information on the management of each condition, including surgical and medical treatments, physical therapy, patient education, monitoring, and prognosis helpful list of references provided for each condition
  • Includes condensed discussions of relevant in-depth information such as etiology and pathogenesis
Description A quick reference for the diagnosis and treatment of many orthopedic conditions.
Info Skyscape, Inc.
Customer Service: 508-460-6500
Web site: http://www.skyscape.com/index/home.aspx

Related medicine products :

1. Griffiths 5-Minute Clinical Consult 2005 for PDA
2. The 5-Minute Neurology Consult
3. 3M™ Steri-Drape™ General Orthopaedic Surgical Packs
4. Orthopaedic Salvage System
5. General Orthopaedics for PDA
6. ORTHOCORD Orthopaedic Suture
7. ChartLogic Orthopaedic Surgery Electronic Medical Office
8. AllMeds for Orthopaedics
9. AcerMed EMR Orthopaedics Edition
10. Fast Facts: Orthopaedic Review
11. 3.5V Pneumatic Consulting Otoscope
Product includes all 15 Lexi-Comps databases. Includes Lexi-drugs, the official reference of the American Pharmacists Association and the National Professional Society of Pharmacists.
...fety Knife with BD Xstar Blade includes a speciall...tects the blade in prodedure and handling. The Xs...ess for manufacturing surgical blades. This propr...nsistency. The arch style, single-bevel geometry ...
Electric high speed system.
The Durafuge 100 spins swing-out rotors at 4000 rpm and fixed-angle rotors at up to 6300 rpm.
Medicine Products:
(Date:12/3/2008)...ire-FirstCall/ -- Forest Laboratories, Inc. (NYSE:... of an unsolicited mini-tender offer by TRC Capita...investment company. Forest Laboratories has recei....0 million outstanding shares of the company,s com...f its outstanding shares. The offer price of $20....
(Date:12/3/2008)...swire/ -- The Belmont(R) Rapid Infuser, a,medical...ls to treat wounded,soldiers, civilians, and enem...,save the life of an Omaha, NE Police Officer. , ...affic stop. One of the bullets,hit him in the abd...rtery. , "Injury to this area is often leth...
(Date:12/3/2008)...PRNewswire-FirstCall/ -- MAP,Pharmaceuticals, Inc...ny, will,participate in a panel discussion titled...nditions" at the 2008 RBC Capital Markets Healthca... 10:00 am (ET) in New York City. , A live w...n the Investor,Relations section of MAP Pharmaceu...
(Date:12/3/2008)...herapeutic guidelines, , , WEDNESDAY,...wo blood pressure drugs was more effective than a ...rious cardiovascular problems and death in people ...t included more than 11,000 patients in the United... The patients took either a tablet containing bena...
Breaking Medicine News(10 mins):Health News:Forest Laboratories Responds To Unsolicited Mini-Tender Offer 2Health News:Forest Laboratories Responds To Unsolicited Mini-Tender Offer 3Health News:Belmont(R) Rapid Infuser Helps Save Officer's Life 2Health News:Blood Pressure Pill Combo More Effective Than Diuretics 2
...ple scoring system for use by physicians predicts ... named transient ischemic attack, known as TIA and...dy. About 240,000 TIAs are diagnosed every year ... in the United Kingdom. A TIA is a serious conditi...
...ehydrogenase (ADH) is one of the major enzymes inv... polymorphic at two loci, ADH1B and ADH1C.// The ...een linked with protection from alcohol dependence...the relationship between the ADH1B*3 allele and al...
...ter six global acquisitions last year, India's Ran...acquire the generic drugs business of German// pha...er $5 billion. ‘We are in talks with private equi...'s chief executive Malvinder Singh said on the mar...
...recent Cochrane Review concluded antidepressants b...’s chances //of giving up smoking and have few sid...tors (SSRIs) such as fluoxetine (Prozac) are not e...s are known to help people quit smoking, not every...
Other Medicine News:Health News:New Tool Improves Prediction of Stroke Risk 2Health News:Alcohol Dehydrogenase Gene may Protect from Developing Alcoholism 2Health News:Alcohol Dehydrogenase Gene may Protect from Developing Alcoholism 3
(Date:12/2/2008)...ll., Dec. 2 Horizon Therapeutics, ... today announced that two pivotal,Phase 3 trials ...ate, HZT-501,met all primary endpoints. HZT-501,...uct containing ibuprofen and famotidine, demonstra...incidence of non-steroidal,anti-inflammatory drug...
(Date:12/1/2008)...Dec. 2 New research has...lice computed tomography (CT) scanner in an emerge...stroke victims who receive a potentially life-savi...orth Shore Medical Center (NSMC)-Salem Hospital in...al meeting of the Radiological Society of North Am...
(Date:12/1/2008)..., Md., Dec. 1 Vanda Phar...tion in The Lancet , one of the world,s leading m... novel circadian regulator, experimental compound ...nam et al(1) is entitled "Melatonin agonist tasime...-time shift: two randomised controlled multicentre...
(Date:12/1/2008)..., Dec. 1 S*BIO Pte Ltd today annou...of SB1518, a potent and orally-active JAK2 inhibit...tients with chronic idiopathic myelofibrosis (CIMF...he safety and tolerability of SB1518 in patients w...s. The Phase 1 part of the study will assess the ...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Rutgers physicist earns prestigious Packard Foundation Science and Engineering Fellowship 1231 1Rutgers physicist earns prestigious Packard Foundation Science and Engineering Fellowship 1231 2The Silent Killer Ovarian Cancer on Your Cancer Today 28TM 29 3528 1The Silent Killer Ovarian Cancer on Your Cancer Today 28TM 29 3528 2Washington Capitals to Visit Patients at Childrens National Medical Center Announce Launch of Initiative to Fight Pediatric Cancer 3524 1MacAndrews 26 Forbes Names Barry F Schwartz as Executive Vice Chairman 1228 1MacAndrews 26 Forbes Names Barry F Schwartz as Executive Vice Chairman 1228 2
...stCall/ -- Boston,Scientific Corporation today wel... of of Cardiology (JACC) reviewing the TAXUS ATLAS...ond-generation,TAXUS(R) Liberte(TM)(1) paclitaxel-...edition of JACC concluded that the shorter,procedu...e Stent,system compared to the TAXUS(R) Express2(T...
...tiple Myeloma,Presented at the American Society of...une 04, 2007 /PRNewswire-FirstCall/ -- Pharmion,Co...ase III study,demonstrating that the addition of T...rvival (OS) by 17.6 months in patients aged 75,or ...ed to the,current standard of care. These results ...
Other Medicine Technology:Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 2Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 3Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 4Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 2Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 3Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 4Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 5Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 6